The DOI matches its Crossref record; the references it cites are not checked yet.
Targeting T Cell–Driven Attenuates Doxorubicin in Cardiotoxicity
Abstract
Anthracycline-induced cardiotoxicity remains a major limitation in the clinical use of agents such as doxorubicin (DOXO), adversely affecting both quality of life and long-term outcomes in patients with cancer. Chronic inflammation has been increasingly recognized as a central mechanism underlying DOXO-mediated cardiac injury; however, the specific immune mediators involved are not fully elucidated. The present study aimed to define the role of interleukin-1β (IL-1β), a key pro-inflammatory cytokine, in the development of cardiac dysfunction following DOXO exposure, and to assess the therapeutic potential of its inhibition using 01BSUR, a surrogate of canakinumab.Using a murine model of DOXO-induced cardiotoxicity, we show that DOXO administration leads to elevated circulating levels of IL-1β, which are significantly associated with impaired cardiac function. Notably, T lymphocytes, rather than macrophages, were identified as the predominant source of IL-1β among circulating immune cells. Mechanistically, DOXO triggered activation of the canonical inflammasome pathway, as evidenced by NFκB phosphorylation, caspase-1 cleavage, and subsequent IL-1β maturation. Pharmacological inhibition with 01BSUR, an anti-interleukin-1β monoclonal antibody, attenuated inflammasome activation, reduced both systemic and myocardial inflammation, and resulted in significant improvement in cardiac functional parameters.Taken together, our findings identify T lymphocyte–derived IL-1β as a previously unrecognized mediator of DOXO-induced cardiotoxicity and support IL-1β inhibition as a promising translational strategy to mitigate cardiac injury in patients undergoing anthracycline-based chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Metadata
- Authors
- Sorriento, D., Fiordelisi, A., Gambardella, J., Cerasuolo, F. A., Avvisato, R., Buonaiuto, A., Varzideh, V., Jankauskas, S. S., Prevete, N., Menale, C., Santulli, G., & Iaccarino, G.
- Publisher
- Elsevier BV
- Published
- 2026
- Cited by
- 0
- Type
- Preprint
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeting T Cell–Driven Attenuates Doxorubicin in Cardiotoxicity . https://app.cochat.ai/papers/10.2139/ssrn.6869083
- The paper
- Sorriento, D., Fiordelisi, A., Gambardella, J., Cerasuolo, F. A., Avvisato, R., Buonaiuto, A., Varzideh, V., Jankauskas, S. S., Prevete, N., Menale, C., Santulli, G., & Iaccarino, G. (2026). Targeting T Cell–Driven Attenuates Doxorubicin in Cardiotoxicity . https://doi.org/10.2139/ssrn.6869083
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.